FDA staff: Gilead's Truvada may help reduce HIV risk

WASHINGTON (Reuters) - Gilead Sciences Inc's Truvada tablets appear safe and effective for reducing the risk of HIV infection, U.S. regulators said on Tuesday. But they recommended a cautious approach for using the drug in efforts to prevent the virus that causes AIDS.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/lwOTjFjkmdo/us-usa-aids-truvada-idUSBRE8470PY20120508

internet business Current news latest news top news recent news save money